Bradford, W. A. K. P. N. T. S. a.
S. O., 2002. Direct to Consumer Advertising and Cholesterol Lowering Drugs. Journal
of Law and Economics, Volume 45(2), pp. 673-690..
Basics of Drug Ads. Online
Available at: https://www.fda.gov/Drugs/ResourcesForYou/Consumers/PrescriptionDrugAdvertising/ucm072077.htm
Accessed 5 December 2017.
a., 2010. voxeu.org. Online
Available at: http://voxeu.org/article/consumer-adverts-pharmaceuticals-impact-prices-and-sales
www.ukessays.com. direct-to-consumer-advertising-marketing-essay. Online
Available at: https://www.ukessays.com/essays/marketing/direct-to-consumer-advertising-marketing-essay.php
Today in internet we find all the sources
but about DTCPA practices of UK I didn’t found so much accurate information
which can directly strike on the topic that is Effectiveness of DTC Pharma
Advertisements in Communicating Drug Risk. The Question Answer asked from the
consumer had raised the problem in communication. Due to communication problem
I gone through some of the problem when doing the exercise of Q/A session. Although
I met various language proficiency people during survey and it was very
difficult to understand my question and take their feedback but I improved my
interview skills over a period of time in order to make it work effectively.
learning from findings and analysis in while completing of my report I find
some challenges which were not easy to overcome. In the collection of
information of DTCPA ads from internet sources was difficult as there was a
shortage of DTCPA based literature which focused on the perception of the
consumers regrading DTCPA, majority of the studies focused on DTCPA from the
perspective of physicians and the relationship between patients and physicians.
Apart from that the main concern I found at the time of survey where I found myself
to be lacking in confidence to seek the answers of people. Further many a times
the respondents were not sure about their answer which challenge my findings on
So, mainly my
learning depend on my findings and analysis which say that the side effects is only to meet the regulatory
requirement for DTCPA which provide accurate information about drugs and pharma
company is using DTCPA as tool to make and generate profit.
I was also able to learn
that a significant proportion of the sample consumed the drugs as advertised by
DTCPA irrespective of the fact that the accurate side effect details for the
same was not communicated in these DTCPA. I was able to find that similar analysis are also found in the previous findings which was in lines
with the findings of my study based on the feedback taken from consumers. I was
able to learn that one of the major objectives of DTCPA from the perspective of
the pharma companies was to increase their revenue for non-prescription drugs.
The consumers who purchased such drugs are often found to become habituated for
consuming such drugs for their health issues.
This report present the
analysis from quantitative way which consist of structured questionnaire
session with different segment of consumer. Survey highlights
the important understanding which make me understand that all the major side
effects is not mentioned and pharma companies is their only for selling the
product but there is a systematic selling of authorised and non-authorised
drugs which is not working but on the same time the DTCPA problem of side
effects in UK when surveyed was found to be very low.
My findings and analysis was based on two hypothesis that is Majority of consumers
are aware about DTCPA or Consumers of drugs find DTCPA to be effective in
communicating the major side effects and contradictions of the drugs. This help
me to find the effect of DTCPA on
consumer is positive or negative for which I am doing this report. (Saffer, 2010).
through from my research methodology I came to know that DTCPA is improvising
in three sector mainly that is consumer risk, respondents feedback and
advertisement knowledge. People are not totally aware about the facts and the
side effects of the drugs which they see on ads. DTCPA give them very low
information and only work to make profit other than working on their health and
safety. DTC ads mislead consumers about the risk-benefit trade-offs of prescription
In the starting
of the report I understand what DTCPA is and what is its
understanding amongst the general public in the UK market regarding the
information given by DTCPA and to explain the scenario of DTCPA for
non-prescribed drugs which is easily available in UK. I learn that Direct to
Consumer pharmaceutical advertisements (DTCPA) has grown rapidly in the past
several decades and is now the most permanent type of health communication that
the public encounters. Some of the important factor
which had impacted pharmaceutical prices making it very hard to evaluate the
increase in prescription drug spending. From all the findings I find that DTCPA
is both beneficial and detrimental to the public health which effects and
contraindications of a drug’s effectiveness. (Bradford, 2002)
In the going
through the findings of my evidence I had conduct a survey which help me to
complete my major of work and give me real understanding about how effective is
DTCPA ads. Every question was related to the DTCPA. Although I met various
language proficiency people during survey and it was very difficult to
understand my question and take their feedback but I make it on working. Due to
communication problem I gone through some of the problem when doing the
exercise of Q/A session. (UKessays, 2015)
experience is all about experience which we learn from interaction, course,
program which can be done in traditional or non-traditional academic settings.
In this report I will describe my own understanding from the topic concerning
to DTCPA ads and their content. I will provide my evidence which contributed on
my findings. (FDA, 2017)